Soleno Therapeutics (NASDAQ:SLNO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soleno Therapeutics Stock (NASDAQ: SLNO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 525.04K
Day Range	- - -
52 Wk Range	3.69 - 53.82
Market Cap	$1.85B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	15.99%
Days to Cover	3.56

Recent News

Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker

NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.

Piero Cingari

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQ:AMZN) on Tuesday and Apple Inc.

Piero Cingari

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Soleno Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics fo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Soleno Therapeutics (SLNO) stock?

You can purchase shares of Soleno Therapeutics (NASDAQ:SLNO) through any online brokerage.

View our list of the best stock brokerages

Who are Soleno Therapeutics (SLNO) competitors?

Other companies in Soleno Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC) and Nurix Therapeutics (NASDAQ:NRIX).

What is the target price for Soleno Therapeutics (SLNO) stock?

There is no analysis for Soleno Therapeutics.

What is the forecast for Soleno Therapeutics (SLNO) stock?

Soleno Therapeutics has a consensus price target of $60.33.

Current stock price for Soleno Therapeutics (SLNO)?

The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $50.21 last updated July 15, 2024 at 4:00 PM EDT.

Does Soleno Therapeutics (SLNO) pay a dividend?

There are no upcoming dividends for Soleno Therapeutics.

When is Soleno Therapeutics (NASDAQ:SLNO) reporting earnings?

Soleno Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is Soleno Therapeutics (SLNO) going to split?

There is no upcoming split for Soleno Therapeutics.

What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Soleno Therapeutics

Soleno Therapeutics (SLNO) Forecast